Harte Hanks, Inc. (HHS) financial statements and ratios from SEC XBRL: revenue $159.57M (TTM), net margin -0.5%, revenue growth -13.9% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $159.57M |
| Net Margin | -0.5% |
| Revenue Growth (YoY) | -13.9% |
| EPS Growth (YoY) | -97.3% |
| FCF Growth (YoY) | -33.3% |
| Price / Book | 1.80 |
| Price / Sales | 0.18 |
| FCF Yield | -31.1% |
| DCF Value (model) | $0.89 |
| DCF Upside vs Price | -76.1% |
| Altman Z-Score | 14.60 (safe) |
| Sector P/E (Technology) | 33.9 |
HHS overview · HHS earnings · HHS KPIs · HHS investor relations · HHS ownership · HHS peers · HHS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.